Dual-Stimulus PROTAC Activation for Selective Protein Degradation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing targeted protein degraders like PROTACs face challenges in achieving selective protein degradation while minimizing off-target effects, particularly in tumor treatments, and single-stimulus pro-PROTACs can cause unintended toxicity.

Innovation Solution

Development of dual-stimulus responsive proteolysis targeting chimeras (PROTACs) that require both stimuli to activate protein degradation, preventing recruitment in the absence of either stimulus, and utilizing a target binding moiety, linker moiety, and ubiquitin ligase-recruiting moiety with first and second stimulus-reactive moieties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If single-stimulus pro-PROTACs are used to enable prodrug-based strategies, then promise of selective activation is achieved, but unintended toxicity occurs due to insufficient selectivity

Engineering Contradiction:
ImproveselectivityVSAvoidoff-target effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The pro-PROTAC molecule is segmented into two distinct stimulus-reactive moieties (first stimulus-reactive moiety and second stimulus-reactive moiety) that must both be activated for the PROTAC to become functional. This segmentation ensures that neither stimulus alone can trigger off-target effects, as both conditions must be simultaneously met for activation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The PROTAC is designed in an inactive precursor form (pro-PROTAC) that requires preliminary activation by two specific stimuli before becoming functional. This preliminary action ensures that the active compound is only generated when both stimulus conditions are satisfied, preventing premature or unintended activation in off-target tissues.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If conventional PROTACs are used to degrade target proteins, then protein degradation capability is achieved, but off-target effects increase due to lack of conditional activation

Engineering Contradiction:
Improveprotein degradationVSAvoidtoxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The PROTAC exhibits different functional qualities in different local conditions: it remains inactive in tissues where either stimulus is absent, and becomes active only in the specific local environment where both stimuli are present (e.g., tumor microenvironment). This local quality differentiation enables selective protein degradation at the target site while sparing off-target tissues.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The activation state of the PROTAC changes based on the presence or absence of specific stimulus parameters. The molecule transitions from an inactive state (when either stimulus is absent) to an active state (when both stimuli are present), allowing controlled protein degradation only under the desired parametric conditions.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If dual-stimulus responsive PROTACs are developed to enhance specificity, then off-target effects are reduced, but device complexity increases due to multiple stimulus-reactive moieties

Engineering Contradiction:
ImprovespecificityVSAvoidmolecular structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The dual-stimulus responsive moieties are integrated into a single PROTAC molecule that maintains the core functions of target binding and ubiquitin ligase recruitment. The additional stimulus-reactive components serve multiple purposes: they provide conditional activation control and can be designed to respond to biologically relevant stimuli, thus adding functionality without proportionally increasing complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20260053934A1Dual action only proteolysis targeting chimeras and uses thereof
Publication Date: 2026.02.26 UNIV OF MASSACHUSETTS
  • US20260053934A1 patent drawing
  • US20260053934A1 patent drawing
  • US20260053934A1 patent drawing

AI summary

A proteolysis targeting chimera is provided of Formula I:wherein: T includes a target binding moiety capable of binding to a target protein; L includes a linker moiety; and U includes a ubiquitin ligase-recruiting moiety capable of binding a ubiquitin ligase; wherein any of T, L, or U further includes a first stimulus-reactive moiety S1, wherein S1 is reactive to a first stimulus; and wherein any of T, L, or U further includes a second stimulus-reactive moiety S2, wherein S2 is reactive to a second stimulus, wherein the second stimulus is different than the first stimulus.